Treatment of Pulmonary DS-TB During Pregnancy

This protocol covers drug-susceptible pulmonary tuberculosis (DS-TB) in the specific context of pregnancy — a setting where the benefits of prompt, effective treatment must be weighed alongside the physiological and nutritional demands of the pregnant patient.

Clinical Scenario

The patient has confirmed pulmonary DS-TB and is currently pregnant. The clinical picture requires addressing active TB disease while accounting for the particular needs of pregnancy throughout the treatment course.

Treatment Approach

Management follows a standard multi-drug anti-TB regimen that is considered safe in pregnancy, complemented by a vitamin supplement to meet the specific nutritional demands this population faces. The complete regimen structure and supporting clinical guidance are available in the full protocol.

Clinical Goals

The primary markers of treatment success are conversion of the sputum culture to negative and measurable improvement of TB symptoms.

Instant Access to Structured Evidence-Based Regimens

References

Pregnant women are usually treated with the standard 6-month 2HRZE/4HR regimen.
Experts have suggested using pyridoxine to complement the anti-TB regimen in pregnancy, because deficiency is more likely to occur than in the general population.
Standard treatment for DS-TB is considered safe in pregnancy and outweighs the grave risks posed by untreated TB.
For pulmonary DS-TB, the most important evidence of improvement is conversion of the sputum culture to negative.

View source ↗